SCHEMBL5606940

SCHEMBL5606940

CCC(=Cc1ccc(O)cc1)C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 5/20 0.46
ESR1 P03372 3/20 0.44
ESR2 Q92731 2/20 0.44
ALDH1A1 P00352 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
EPHX2 P34913 1/20 0.37
ABCG2 Q9UNQ0 2/20 0.37
TYR P14679 1/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5607384 0.88 MIF (0.43) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL9737066 0.88 ALDH1A1 (0.38) ALDH1A1KDM4EMEN1KMT2AEPHX2
SCHEMBL5607567 0.85 MIF (0.47) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL5606981 0.82 ESR1 (0.47) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL15248883 0.81 CA12 (0.53) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL5606769 0.81 CA12 (0.53) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL5607136 0.80 NR1H4 (0.59) ALDH1A1KDM4EMEN1KMT2AABCG2
SCHEMBL5606938 0.79 CA12 (0.48) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL5606934 0.79 CA12 (0.48) MIFESR1ESR2ALDH1A1KDM4E
SCHEMBL5606469 0.79 ALDH1A1 (0.50) MIFESR1ESR2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids TAKASAGO INTERNATIONAL CORPORATION (JP) 2007-06-21 US disclosed
EP-1687250-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS Takasago International Corporation (JP) 2006-08-09 EP disclosed
WO-2005051882-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE 3-(4-HYDROXYPHENYL)PROPIONIC ACIDS TAKASAGO INTERNATIONAL CORPORATION (JP) 2005-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142472-A1 Process for producing optically active 3-(4-hydroxyphenyl)proprionic acids ALDH1A2, ALDH1A3, GRHPR MIF 2713/4885ESR1 2687/4885ESR2 3089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.